Reversible posterior leukoencephalopathy syndrome and bevacizumab.
Ozcan
Cevher
C
Wong
Stuart J
SJ
Hari
Parameswaran
P
D000230:Adenocarcinoma / Q000188:drug therapy; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications; D020343:Hypertensive Encephalopathy / Q000139:chemically induced*; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab